Cara Therapeutics Inc

CARA

Sector
Healthcare

Industry
Biotechnology




Buy / Sell (dollars)

1 Month

0% 0% Complete (success)
0% 0% Complete (danger)
$0.00
avg. $0.00
$0.00
avg. $0.00

Buy/Sell Ratio

0

Transactions

0

Filers

0

3 Month

23.3% 23.3% Complete (success)
76.7% 76.7% Complete (danger)
$225,536.46
avg. $75,178.82
$744,474.03
avg. $248,158.01

Buy/Sell Ratio

0.303

Transactions

6

Filers

4

12 Month

12.3% 12.3% Complete (success)
87.7% 87.7% Complete (danger)
$555,586.98
avg. $46,298.92
$3.958M
avg. $329,821.78

Buy/Sell Ratio

0.14

Transactions

31

Filers

8

24 Month

5.7% 5.7% Complete (success)
94.3% 94.3% Complete (danger)
$706,586.98
avg. $29,441.12
$11.589M
avg. $482,863.96

Buy/Sell Ratio

0.061

Transactions

45

Filers

12

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers